DigestRedComo funciona
Red
/
Empresas
LE
No verificado

LEO Pharma

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

39 Comunicados de prensa

Ver todos los comunicados de prensa
17/11/2025
Industria
Biotecnología
Farmacéutica
Salud
Medicina - Varios
LEO Pharma Announces Positive Topline 32-Week Key Results in ADHAND Trial
Fuente
LEO Pharma
Editor
Business Wire
1.00
0
06/11/2025
Mercado de valores
Biotecnología
Sanidad
Farmacéutica
Salud
LEO Pharma Delivers 8% Revenue Growth at CER in 9M 2025 and Updates Full-Year Outlook
Fuente
LEO Pharma
Editor
Business Wire
1.00
0
05/11/2025
Biotecnología
Sanidad
Farmacéutica
Salud
Industria
LEO Pharma Announces NICE Recommendation of Reimbursement in England and Wales
Fuente
LEO Pharma
Editor
Business Wire
1.00
0
03/11/2025
Sanidad
Salud
Medicina - Varios
Mercado laboral
LEO Pharma Strengthens Leadership in Medical Dermatology with the Appointment of Sophie Lamle as Chief Development Officer
Fuente
LEO Pharma
Editor
Business Wire
1.00
0
21/10/2025
Eventos
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
LEO Pharma Reinforces Leadership in Medical Dermatology with New Data from Across Its Portfolio at 2025 Fall Clinical Dermatology Conference
Fuente
LEO Pharma
Editor
Business Wire
1.00
0
01/10/2025
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Industria
LEO Pharma Closes Deal for Spevigo®
Fuente
LEO Pharma
Editor
Business Wire
1.00
0
19/09/2025
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Industria
LEO Pharma Presents Late-Breaking Data at EADV 2025 Showing Week 16 Tralokinumab Response Predicts Long-Term Response in Moderate-to-Severe Atopic Dermatitis
Fuente
LEO Pharma
Editor
Business Wire
1.00
0
17/09/2025
Eventos
Industria
Salud
Sanidad
Medicina - Varios
Farmacéutica
Biotecnología
LEO Pharma presents two late-breaking abstracts for temtokibart reporting positive Phase 2b efficacy, safety and biomarker results in moderate-to-severe atopic dermatitis at the 2025 EADV Annual Meeting in Paris
Fuente
LEO Pharma
Editor
Business Wire
1.00
0
15/09/2025
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Industria
LEO Pharma Takes Centre Stage With its Largest-Ever Scientific Programme at EADV 2025
Fuente
LEO Pharma
Editor
Business Wire
1.00
0
18/08/2025
Multimedia
Biotecnología
Farmacéutica
Salud
Mercado de valores
LEO Pharma Delivers 7% Revenue Growth at CER in H1 2025 and Achieves Key Milestones Enabling Future Growth
Fuente
LEO Pharma
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0